Matthew Sykes
Stock Analyst at Goldman Sachs
Total Price Targets
17
Stocks Covered
14
Sectors
Healthcare
Most Recent
May 5, 2025
Notable Calls (Last 12 Months)
Stocks Covered by Matthew Sykes
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| SHC | Sotera Health Company | $17.00 | $15.64 | +8.7% | 1 | May 5, 2025 |
| TMO | Thermo Fisher Scientific Inc. | $610.00 | $469.31 | +30.0% | 2 | Apr 23, 2025 |
| DHR | Danaher Corporation | $240.00 | $175.31 | +36.9% | 3 | Apr 22, 2025 |
| CTKB | Cytek Biosciences, Inc. | $5.25 | $4.60 | +14.1% | 1 | Feb 2, 2025 |
| ICLR | ICON Public Limited Company | $370.00 | $112.39 | +229.2% | 1 | Jun 6, 2024 |
| CRL | Charles River Laboratories International, Inc. | $290.00 | $165.56 | +75.2% | 1 | Jun 6, 2024 |
| FTRE | Fortrea Holdings Inc. | $28.00 | $12.02 | +133.0% | 1 | Jun 6, 2024 |
| IQV | IQVIA Holdings Inc. | $270.00 | $156.85 | +72.1% | 1 | Jun 6, 2024 |
| A | Agilent Technologies, Inc. | $145.00 | $114.72 | +26.4% | 1 | May 30, 2024 |
| PACB | Pacific Biosciences of California, Inc. | $2.50 | $1.59 | +56.7% | 1 | Apr 18, 2024 |
| TWST | Twist Bioscience Corporation | $45.00 | $60.67 | -25.8% | 1 | Jan 17, 2024 |
| AVTR | Avantor, Inc. | $40.00 | $7.97 | +401.6% | 1 | Jun 4, 2021 |
| NEO | NeoGenomics, Inc. | $55.00 | $9.31 | +490.8% | 1 | Jun 3, 2021 |
| GH | Guardant Health, Inc. | $160.00 | $87.52 | +82.8% | 1 | Jun 3, 2021 |
Recent Activity
- May 5, 2025— Set$17.00price target onSHC(Sotera Health Company)
- Apr 23, 2025— Set$610.00price target onTMO(Thermo Fisher Scientific Inc.)
- Apr 22, 2025— Set$240.00price target onDHR(Danaher Corporation)
- Feb 2, 2025— Set$5.25price target onCTKB(Cytek Biosciences, Inc.)
- Jan 15, 2025— Set$250.00price target onDHR(Danaher Corporation)
- Jun 6, 2024— Set$270.00price target onIQV(IQVIA Holdings Inc.)
- Jun 6, 2024— Set$290.00price target onCRL(Charles River Laboratories International, Inc.)
- Jun 6, 2024— Set$28.00price target onFTRE(Fortrea Holdings Inc.)
- Jun 6, 2024— Set$370.00price target onICLR(ICON Public Limited Company)
- May 30, 2024— Set$145.00price target onA(Agilent Technologies, Inc.)
- Apr 18, 2024— Set$2.50price target onPACB(Pacific Biosciences of California, Inc.)
- Jan 17, 2024— Set$45.00price target onTWST(Twist Bioscience Corporation)
- Jan 30, 2022— Set$360.00price target onDHR(Danaher Corporation)
- Sep 23, 2021— Set$690.00price target onTMO(Thermo Fisher Scientific Inc.)
- Jun 4, 2021— Set$40.00price target onAVTR(Avantor, Inc.)
- Jun 3, 2021— Set$55.00price target onNEO(NeoGenomics, Inc.)
- Jun 3, 2021— Set$160.00price target onGH(Guardant Health, Inc.)
Frequently Asked Questions
Who is Matthew Sykes?
Matthew Sykes is a stock analyst at Goldman Sachs covering 14 stocks primarily in Healthcare. They have issued 17 price targets since Jun 3, 2021.
What stocks does Matthew Sykes cover?
Matthew Sykes currently covers 14 stocks, including DHR, TMO, SHC, CTKB, ICLR.
What is Matthew Sykes's latest price target?
Matthew Sykes's most recent price target was $17.00 on SHC (Sotera Health Company), set on May 5, 2025.
What is Matthew Sykes's highest price target?
Matthew Sykes's highest issued price target is $690.00 on TMO, set on Sep 23, 2021.
More Analysts at Goldman Sachs
Coverage based on publicly published price targets. Not investment advice.